2018 Complication Individual Medical 
FDA Law Blog
DECEMBER 13, 2023
GeMDAC was established to advise FDA regarding treatments under the purview of CDER’s Division of Rare Diseases and Medical Genetics (DRDMG), within the Office of Rare Diseases, Pediatrics, Urologic and Reproductive Medicine. Note that FDA is currently soliciting applications to staff this committee.
PEMBlog
APRIL 20, 2023
Emicizumab (Hemlibra) was approved in 2018 for routine bleeding prophylaxis in hemophilia A with or without inhibitors. Rather, it can change the bleeding phenotype from severe hemophilia to mild hemophilia – thus potentially reducing the risk of complications. Patients on emicizumab will have it listed on their medication list.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
GeriPal
MAY 19, 2022
I think part of it’s the math, but I think what really happened is, I think the story here is that in 2018, MD Anderson published this really landmark study by Dr. Reddy and her colleagues about going from IV Dilaudid to other to oral Dilaudid, oral hydromorphone, I should say, oral morphine and oral oxycodone. The old table, 1.5
GeriPal
JUNE 8, 2023
When I’m on palliative care consults and attending in our hospice unit we have to counsel patients about deprescribing and de-intensifying diabetes medications. Our last podcast was with Laura Petrillo in 2018 – 5 years ago seems ancient history – though many of the points still apply today (e.g. How high is too high?
FDA Law Blog
JULY 10, 2023
Lenz, Principal Medical Device Regulation Expert — It takes a significant amount of time, cost, and effort to prepare a premarket notification 510(k) submission. In this blog post, we will first briefly outline the procedural steps in the 510(k) review process for medical devices. By Philip Won & Adrienne R.
The Clinical Problem Solvers
FEBRUARY 8, 2023
Between 2007 – 2019, Black individuals experienced a higher death rate for opioid overdose deaths than any other racial or ethnic group. These narratives have vilified individuals who would benefit from comprehensive, person-centered substance use treatment, rather than incarceration and other adverse harms.
GeriPal
JULY 21, 2022
Eric: For those of you don’t know, Emmy was on our podcast back in 2018 … man, pre-COVID times. If they’re in a major car crash, they’re going to have more long-term complications probably than a 20-year-old would. That’s where it really gets to this individual risks and balances, individual situation.
Expert insights. Personalized for you.
59 
Let's personalize your content